Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-31

Clinical Trial Update: Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of LX4211 in combination with metformin in adults with Type 2 Diabetes Mellitus who have inadequate gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LX4211 (LX4211)
  • metformin (metformin)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2014-10-31